Credit Suisse lowered its target price for Innovent (01801) to HK$52 from HK$57 and maintained its "outperform" rating.
The research house said it now estimates FY23 topline growth at 33%. After model adjustment, the FY23/24E EPS is lower by 15%/59%.
【香港好去處】2025去邊最好玩？etnet為你提供全港最齊盛事活動，所有資訊盡在掌握！► 即睇
